Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

2020 Neuro-Oncology 1,014 citations

Abstract

Abstract Glioblastomas are the most common form of malignant primary brain tumor and an important cause of morbidity and mortality. In recent years there have been important advances in understanding the molecular pathogenesis and biology of these tumors, but this has not translated into significantly improved outcomes for patients. In this consensus review from the Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO), the current management of isocitrate dehydrogenase wildtype (IDHwt) glioblastomas will be discussed. In addition, novel therapies such as targeted molecular therapies, agents targeting DNA damage response and metabolism, immunotherapies, and viral therapies will be reviewed, as well as the current challenges and future directions for research.

Keywords

GlioblastomaMedicineOncologyCurrent (fluid)Internal medicineClinical OncologyCancer researchCancerEngineering

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
review
Volume
22
Issue
8
Pages
1073-1113
Citations
1014
Access
Closed

External Links

Citation Metrics

1014
OpenAlex

Cite This

Patrick Y. Wen, Michael Weller, Eudocia Q. Lee et al. (2020). Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-Oncology , 22 (8) , 1073-1113. https://doi.org/10.1093/neuonc/noaa106

Identifiers

DOI
10.1093/neuonc/noaa106